The prescribed use of testosterone products has been linked to serious injury and deaths. Now, according to the latest press release below, the number of cases has reached a magnitude where a national lawsuit against the manufacturers seems likely.
August 19, 2014 via Business Wire. A law firm is investigating filing the first nationwide class action lawsuit against the makers of testosterone as a result of serious injuries and deaths linked to the products. Users prescribed with low testosterone or “Low T” therapy are claiming testosterone is to blame for dangerous side effects such as:
- Heart attack
- Blood clots
- Deep vein thrombosis
- Pulmonary embolism
… leading to serious injuries and death.The suit would claim that manufacturers knew of these risks and failed to warn the public. It would also claim that manufacturers aggressively marketed testosterone by misleading potential users about the safety and efficacy of low testosterone treatments; ultimately failing to protect users from serious, life-threatening, adverse medical events. Recent studies indicate that men over 65 have a double risk of a heart attack within 90 days of starting hormone therapy. Among men under the age of 65 with a history of heart disease, there is a two-to-three fold increased risk of heart attack. Another study was discontinued due to a high rate of heart attacks. In June, 2014, the U.S. Food and Drug Administration stated that testosterone products can cause dangerous blood clots in the legs and lungs and required drug makers to warn of the risks on testosterone product labels. Testosterone is often administered as a gel, patch, or injection and may include the following products: Androderm (Watson Laboratories), Androgel (Abbott Laboratories and Abbvie, Inc.), Axiron (Eli Lilly and Company), Fortesta (Endo Pharmaceuticals), Striant (Auxilium), Testim (Prasco), Testoderm (Ferring Pharmaceuticals), Testopel (Auxilium), and Vogelxo (Upsher-Laboratories) The Low Testosterone Therapy litigation will seek compensation for those who have died and been injured as a result of their use of testosterone and also seek to establish a medical monitoring fund for those that seek testing. If you have a low testosterone therapy issue or case and would like a confidential evaluation from Ball & Evans and Bonhltzer please contact us.